awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38014920-2CBC4C36-494A-42A2-929B-888CF7745BF7
Q38014920-2CBC4C36-494A-42A2-929B-888CF7745BF7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38014920-2CBC4C36-494A-42A2-929B-888CF7745BF7
Using antibodies to target cancer therapeutics.
P2860
Q38014920-2CBC4C36-494A-42A2-929B-888CF7745BF7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38014920-2CBC4C36-494A-42A2-929B-888CF7745BF7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
49a160a10cfe1d4d322f513cbb92fbb46250fe80
P2860
A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma.